Literature DB >> 10331349

Selective review of key perioperative renal-electrolyte disturbances in chronic renal failure patients.

J Yee1, R Parasuraman, R G Narins.   

Abstract

The medical care of chronic renal failure patients is often complicated by the comorbid conditions of hypertension and coronary artery disease in the perioperative period. The limitations on solute and water excretion imposed by renal dysfunction increase the susceptibility of this population to both salt deficit and surfeit, as well as hyponatremia and hypernatremia perioperatively. Accurate assessment and successful treatment of these complications in renal failure patients require understanding of the concept of electrolyte-free water, proper utilization of diuretics, and calculated prescription of fluid therapy. The presence of hyperkalemia in the adapted renal failure patient generally indicates a severe reduction in glomerular filtration, such that nonrenal hypokalemic treatments are imperative. IV calcium-based therapy and infusion of insulin with glucose represent the mainstays of immediate therapy, and sodium bicarbonate therapy should be given only when severe acidemia is present. Perioperative aggravation of preexistent hypertension is common. Rebound hypertension attributable to injudicious adjustment of the medical regimen should be diligently searched for first, before any new therapies are recommended. Relief of pain or anxiety may be all that is necessary. Briefly acting calcium channel blocker therapy should not be employed in these cases, and smooth IV control by a variety of agents is preferable, the choice of the agent contingent on the clinical scenario.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331349     DOI: 10.1378/chest.115.suppl_2.149s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Absence of AVPR2 copy number variation in eunatremic and dysnatremic subjects in non-Hispanic Caucasian populations.

Authors:  Yi Fu; Zhan Chen; Alexandra I F Blakemore; Eric Orwoll; David M Cohen
Journal:  Physiol Genomics       Date:  2009-12-08       Impact factor: 3.107

2.  Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial.

Authors:  Daniel Z Hodson; Matthew Griffin; Devin Mahoney; Parinita Raghavendra; Tariq Ahmad; Jeffrey Turner; F Perry Wilson; W H Wilson Tang; Veena S Rao; Sean P Collins; Wilfried Mullens; Jeffrey M Testani
Journal:  JACC Heart Fail       Date:  2019-05       Impact factor: 12.035

3.  A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia.

Authors:  Wei Tian; Yi Fu; Anna Garcia-Elias; José M Fernández-Fernández; Rubén Vicente; Patricia L Kramer; Robert F Klein; Robert Hitzemann; Eric S Orwoll; Beth Wilmot; Shannon McWeeney; Miguel A Valverde; David M Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

4.  Daily use of a muscle pump activator device reduces duration of hospitalization and improves early graft outcomes post-kidney transplantation: A randomized controlled trial.

Authors:  Wen Xie; Max A Levine; Shahid Aquil; Katharine Pacoli; Rafid Al-Ogaili; Patrick P Luke; Alp Sener
Journal:  Can Urol Assoc J       Date:  2021-02       Impact factor: 1.862

5.  Effect of intraoperative transesophageal Doppler-guided fluid therapy versus central venous pressure-guided fluid therapy on renal allograft outcome in patients undergoing living donor renal transplant surgery: a comparative study.

Authors:  Divya Srivastava; Sandeep Sahu; Abhilash Chandra; Tanmay Tiwari; Sanjay Kumar; P K Singh
Journal:  J Anesth       Date:  2015-07-28       Impact factor: 2.078

6.  Functional polymorphisms affecting the clinically important arginine-137 residue of AVPR2 do not influence serum sodium concentration at the population level.

Authors:  Yi Fu; Tim Cheetham; David Bourn; Eric Orwoll; David M Cohen
Journal:  Physiol Genomics       Date:  2013-01-29       Impact factor: 3.107

Review 7.  Perioperative fluid management in kidney transplantation: a black box.

Authors:  Maria Helena Calixto Fernandes; Thomas Schricker; Sheldon Magder; Roupen Hatzakorzian
Journal:  Crit Care       Date:  2018-01-25       Impact factor: 9.097

8.  Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis.

Authors:  Satoshi Ito; Tomohisa Nagoshi; Kosuke Minai; Yusuke Kashiwagi; Hiroshi Sekiyama; Akira Yoshii; Haruka Kimura; Yasunori Inoue; Kazuo Ogawa; Toshikazu D Tanaka; Takayuki Ogawa; Makoto Kawai; Michihiro Yoshimura
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

9.  Timing of intraoperative crystalloid infusion may decrease total volume of infusate without affecting early graft function in live related renal transplant surgery: A randomized, surgeon-blinded clinical study.

Authors:  Abhishek Singh; Rashmi Ramachandran; C Chandralekha; Anjan Trikha; Bikash Ranjan Ray; Virinder Kumar Bansal; Sandeep Mahajan; Krishna Asuri; Vimi Rewari
Journal:  Indian J Urol       Date:  2022-01-01

10.  Effects of the Type of Intraoperative Fluid in Living Donor Kidney Transplantation: A Single-Center Retrospective Cohort Study.

Authors:  Seungho Jung; Jeongmin Kim; Juhan Lee; Su Youn Choi; Hye Ji Joo; Bon-Nyeo Koo
Journal:  Yonsei Med J       Date:  2022-04       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.